Patents Assigned to NIKAN PHARMACEUTICALS, LLC
  • ANTAGONISM OF HUMAN FORMYL PEPTIDE RECEPTOR FOR TREATMENT OF DISEASE
    Publication number: 20120231994
    Abstract: The present invention is directed to modulators of eosinophilic and neutrophilic function and the use of such modulators for treatment of eosinophil-associated and neutrophil-associated diseases.
    Type: Application
    Filed: June 2, 2010
    Publication date: September 13, 2012
    Applicant: NIKAN PHARMACEUTICALS, LLC
    Inventor: John D. Benson
  • NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS
    Publication number: 20120216303
    Abstract: The invention features a transgenic mouse that expresses human formyl peptide receptor and methods for producing this mouse. The invention also features methods for the measurement of an inflammatory response, particularly that associated with cystic fibrosis. The methods of the invention also feature methods for determining whether a compound inhibits or prevents the recruitment of neutrophils.
    Type: Application
    Filed: March 12, 2010
    Publication date: August 23, 2012
    Applicant: NIKAN PHARMACEUTICALS, LLC
    Inventor: John D. BENSON
  • TRANSGENIC MICE EXPRESSING HUMAN FORMYL PEPTIDE RECEPTOR
    Publication number: 20100251396
    Abstract: The invention features a transgenic mouse that expresses human formyl peptide receptor and methods for producing this mouse. The invention also features methods for the measurement of an inflammatory response, particularly that associated with cystic fibrosis. The methods of the invention also feature methods for determining whether a compound inhibits or prevents the recruitment of neutrophils.
    Type: Application
    Filed: July 21, 2009
    Publication date: September 30, 2010
    Applicant: NIKAN PHARMACEUTICALS, LLC
    Inventor: John D. BENSON